Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Richardt

Showing results (31-40 of 348) with videos related to

Pageof 35
Sort By:
Journal of Cardiovascular Pharmacology|February 25, 2010
U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanismChristof Burgdorf, Ulrich Schäfer, Gert Richardt, et al.
The Journal of Invasive Cardiology|November 28, 2002
Intracoronary beta radiation for in-stent restenosis in a patient with percutaneously treated hypertrophic cardiomyopathy and coronary artery diseaseDeepak Jain, Volker Geist, Hugo A Katus, et al.
International Journal of Cardiovascular Interventions|September 9, 2005
The AngioGuard: a simplified snare?Ahmed A Khattab, Volker Geist, Ralph Toelg, et al.
Zeitschrift Fur Kardiologie|October 24, 2002
Catheter-induced dissection of the left main coronary artery, the nemesis of an invasive cardiologist A case report and review of the literatureDeepak Jain, Volkhard Kurowski, Hugo A Katus, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptorsUlrich Schäfer, Christof Burgdorf, Astrid Engelhardt, et al.
Journal of Molecular and Cellular Cardiology|February 12, 2004
Human cardiac phospholipase D activity is tightly controlled by phosphatidylinositol 4,5-bisphosphateThomas Kurz, Dorit Kemken, Kenneth Mier, et al.
Canadian Journal of Physiology and Pharmacology|January 16, 2007
Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction sizeDoreen Richardt, Andreas Dendorfer, Ralph Tölg, et al.
JACC. Cardiovascular Interventions|March 21, 2020
Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed TomographyMohammad Abdelghani, Martin Landt, Hussein Traboulsi, et al.
Journal of Cardiovascular Pharmacology|December 23, 2004
Adenylyl cyclase-dependent inhibition of myocardial norepinephrine release by presynaptic adenosine A1-receptorsChristof Burgdorf, Frank Schütte, Thomas Kurz, et al.
Journal of Cardiovascular Pharmacology|February 24, 2006
Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty ratsChristof Burgdorf, Gert Richardt, Frank Schütte, et al.
Pageof 35

Showing results (31-40 of 348) with videos related to

Sort By:
Pageof 35
Journal of Cardiovascular Pharmacology|February 25, 2010
U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanismChristof Burgdorf, Ulrich Schäfer, Gert Richardt, et al.
The Journal of Invasive Cardiology|November 28, 2002
Intracoronary beta radiation for in-stent restenosis in a patient with percutaneously treated hypertrophic cardiomyopathy and coronary artery diseaseDeepak Jain, Volker Geist, Hugo A Katus, et al.
International Journal of Cardiovascular Interventions|September 9, 2005
The AngioGuard: a simplified snare?Ahmed A Khattab, Volker Geist, Ralph Toelg, et al.
Zeitschrift Fur Kardiologie|October 24, 2002
Catheter-induced dissection of the left main coronary artery, the nemesis of an invasive cardiologist A case report and review of the literatureDeepak Jain, Volkhard Kurowski, Hugo A Katus, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptorsUlrich Schäfer, Christof Burgdorf, Astrid Engelhardt, et al.
Journal of Molecular and Cellular Cardiology|February 12, 2004
Human cardiac phospholipase D activity is tightly controlled by phosphatidylinositol 4,5-bisphosphateThomas Kurz, Dorit Kemken, Kenneth Mier, et al.
Canadian Journal of Physiology and Pharmacology|January 16, 2007
Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction sizeDoreen Richardt, Andreas Dendorfer, Ralph Tölg, et al.
JACC. Cardiovascular Interventions|March 21, 2020
Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed TomographyMohammad Abdelghani, Martin Landt, Hussein Traboulsi, et al.
Journal of Cardiovascular Pharmacology|December 23, 2004
Adenylyl cyclase-dependent inhibition of myocardial norepinephrine release by presynaptic adenosine A1-receptorsChristof Burgdorf, Frank Schütte, Thomas Kurz, et al.
Journal of Cardiovascular Pharmacology|February 24, 2006
Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty ratsChristof Burgdorf, Gert Richardt, Frank Schütte, et al.
Pageof 35